INSTI, Tenofovir-Free Regimen DOR/ISL Gains FDA Approval for HIV This fixed-dose, 2-drug combination is a once-daily, ...

Healthcare data’s high fraud utility and broad clinical dependencies make ransomware uniquely harmful, coupling identity ...

A key insight from VESALIUS-CV is how the timing of benefit differs between patients with and without established ...

Ez-PAVE delivers the first direct trial evidence that targeting LDL below 55 mg/dL is superior to below 70 mg/dL in ASCVD ...

The future of systemic therapy for cutaneous squamous cell carcinoma (CSCC) is rapidly evolving, with research focused on ...

Long-acting therapies could be key to engaging unsuppressed patients and closing persistent gaps in HIV care. Despite major ...

Fatima Stanford, MD, MPH exposes obesity health disparities, GLP-1 access hurdles, payer policy fixes, and how stigma in care ...

Panelists explore stroke classification and clinical presentation, highlighting key differences between ischemic and hemorrhagic strokes, the TOAST system for subtype identification, and the ...

Panelists examine the societal impact of stroke by outlining its prevalence, underlying pathophysiology, key modifiable risk factors, and the substantial clinical, economic, and long-term disability ...

Vepdegestrant becomes the first FDA-approved heterobifunctional protein degrader (PROTAC) in breast cancer, targeting ER ...

An emergency stay from the Supreme Court paused a Fifth Circuit decision that would have required in-person clinic dispensing ...

NHATS (2015–2020) analyses treated affordability, housing quality, and neighborhood quality as time-varying exposures and ...